Page last updated: 2024-11-05

urapidil and Urinary Retention

urapidil has been researched along with Urinary Retention in 2 studies

Urinary Retention: Inability to empty the URINARY BLADDER with voiding (URINATION).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamanishi, T2
Yasuda, K2
Kamai, T1
Tsujii, T1
Sakakibara, R2
Uchiyama, T1
Yoshida, K1
Tojo, M1
Hattori, T1
Shimazaki, J1

Trials

1 trial available for urapidil and Urinary Retention

ArticleYear
Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor.
    International journal of urology : official journal of the Japanese Urological Association, 2004, Volume: 11, Issue:2

    Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Aged; Bethanechol; Cholinergic Agents; Do

2004

Other Studies

1 other study available for urapidil and Urinary Retention

ArticleYear
Improvement of urethral resistance after the administration of an alpha-adrenoceptor blocking agent, urapidil, for neuropathic voiding dysfunction.
    Paraplegia, 1994, Volume: 32, Issue:4

    Topics: Adrenergic alpha-Antagonists; Aged; Female; Humans; Male; Middle Aged; Nervous System Diseases; Pipe

1994